o'farrell

REVERSED

1600 Biotechnology and Organic Chemistry
1632 Ex Parte Martuza et al 10/788,410 FREDMAN 103(a) FOLEY AND LARDNER LLP SHEN, WU CHENG WINSTON

This is the essence of an impermissible obvious to try argument, since there is no evidence that the combination had a reasonable expectation of success in treating cancer. Therefore, we see the invention as, at best, an improper use of an obvious to try rationale. In re O’Farrell, 853 F.2d 894, 904 (Fed. Cir. 1988).

O’Farrell, In re, 853 F.2d 894, 7 USPQ2d 1673 (Fed. Cir. 1988) . . 2143.01, 2143.02, 2144.08, 2145

2400 Networking, Mulitplexing, Cable, and Security
2435 Ex Parte Saito 10/105,262 DANG 103(a) MEYERTONS, HOOD, KIVLIN, KOWERT & GOETZEL, P.C. TRUVAN, LEYNNA THANH

2465 Ex Parte Wild et al 10/818,823 POTHIER 102(b)/103(a) SoCAL IP LAW GROUP LLP HSU, ALPUS

3700 Mechanical Engineering, Manufacturing, and Products & Design
3723 Ex Parte Johnsen et al 10/350,640 BAHR 103(a) Kolisch, Hartwell, Dickinson, McCormack & Heuser CHIN, RANDALL E

3900 Central Reexamination Unit (CRU)
3612 Ex Parte RANDALL MFG. Requester and Respondent v.FG PRODUCTS, INC.Patent Owner and Appellant 95/000,326 11/083,041 7214017 COCKS 103(a) OBLON, SPIVAK, MCCLELLAND MAIER & NEUSTADT, L.L.P. FLANAGAN, BEVERLY MEINDL original GORDON, STEPHEN T

AFFIRMED-IN-PART

2800 Semiconductors, Electrical and Optical Systems and Components
2835 Ex Parte Fung 11/591,021 DANG 102(e)/103(a) 102(e) HEWLETT-PACKARD COMPANY CHEN, XIAOLIANG

AFFIRMED

1700 Chemical & Materials Engineering
1727 Ex Parte Ohata et al 10/769,866 NAGUMO 103(a) MCDERMOTT, WILL & EMERY LAIOS, MARIA J

1775 Ex Parte Sand 11/620,238 SCHAFER 103(a) TAYLOR IP, P.C. YOO, REGINA M

2100 Computer Architecture and Software
2161 Ex Parte Both 10/454,389 DANG 112(1)/102(b)/103(a) FISH & RICHARDSON, P.C. PADMANABHAN, KAVITA

2168 Ex Parte Sanders et al 10/776,069 DANG 103(a) Sue Z. Shaper MORRISON, JAY A

2192 Ex Parte Glider et al 10/723,085 BARRY 103a) GIBB & RILEY, LLC WEI, ZHENG

2400 Networking, Mulitplexing, Cable, and Security
2424 Ex Parte Dukes et al 10/752,824 COURTENAY 103(a) YAHOO! INC. SHELEHEDA, JAMES R

2443 Ex Parte Bahar 09/978,224 HOMERE 101/112(2)/103(a) CAHILL VON HELLENS & GLAZER PLC BILGRAMI, ASGHAR H

2451 Ex Parte Schrempp et al 09/910,680 WINSOR 102(b)/103(a) Lowenstein Sandler PC PATEL, DHAIRYA A

2452 Ex Parte Christian et al 09/991,386 HOMERE 103(a) CHRISTOPHER & WEISBERG, P.A. CHANKONG, DOHM

2478 Ex Parte Biran et al 10/733,734 PER CURIAM 103(a) HOFFMAN WARNICK LLC MUSA, ABDELNABI O

2800 Semiconductors, Electrical and Optical Systems and Components
2884 Ex Parte Srivastava et al 11/301,232 GONSALVES 102(b)/103(a) GENERAL ELECTRIC COMPANY LEE, SHUN K

2895 Ex Parte Kammler et al 11/550,631 BISK 102/103(a) GLOBALFOUNDRIES INC. c/o Williams, Morgan & Amerson WITHERS, GRANT S

3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3643 Ex Parte Lang et al 12/101,555 GRIMES 103(a) PRAXAIR, INC. PARSLEY, DAVID J

3689 Ex Parte Samsky et al 10/941,306 KIM 103(a) Ballard Spahr LLP LONG, FONYA M

3700 Mechanical Engineering, Manufacturing, and Products & Design
3762 Ex Parte Goetz et al 11/590,741 MILLS 103(a) IPLM GROUP, P.A. EL-KAISSI, HIBA CARINE
 
3900 Central Reexamination Unit (CRU)
2153 Ex parte AVOCENT REDMOND CORP. Appellant and Patent Owner 90/010,626 09/590,170 6,345,323 SIU 103(a) DAVIDSON BERQUIST JACKSON & GOWDEY LLP CHOI, WOO H original DINH, DUNG C

2153 Ex parte AVOCENT REDMOND CORP. Appellant and Patent Owner 90/010,628 09/683,582 7,113,978 SIU 103(a) DAVIDSON BERQUIST JACKSON & GOWDEY LLP CHOI, WOO H original DINH, DUNG C